Clinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya

Wardani, Erika Martining and Nugroho, Riezky Faisal and Bistara, Difran Nobel and Afiyah, R. Khairiyatul and HASINA, SITI NUR and Septianingrum, Yurike (2022) Clinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya. Open Access Macedonian Journal of Medical Sciences (OAMJMS), 10 (G). pp. 330-334. ISSN 1857-9655

	PDF Clinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya.pdf Download (459kB)
	PDF korespondensi erika martining wardani.pdf Download (224kB)
	PDF korespondensi difran nobel bistara.pdf Download (217kB)
	PDF turnitin erika martining wardani.pdf Download (1MB)
	PDF turnitin difran nobel bistara.pdf Download (1MB)

Abstract

Background : Covid-19 has been declared a global health emergency. Reports of thousands of cases with morbidity and mortality continue to increase every day. The clinical course of patients with comorbidities influences the prognosis and progression of the covid-19 disease. Hypertension is the most common cormorbidity of covid-19 patients with long hospitalizations. Objective : This study aimed to determine the clinical differences between covid-19 patients cormobid and non cormobid . Methods : The study was conducted retrospectively through samples of medical records of inpatients for the period June 1, 2021 – August 31, 2021. The samples were divided into comorbid and non-cormobid groups; each totaling 130 medical records. The sample of the comorbid group was selected by simple random; while the non-cormobid group with the matching process. Data were analyzed using t-test and Wilcoxon. Results : The most common kormobid is hypertension with clinical manifestations of cough, fever, headache, runny nose, painful swallowing, anosmia, shortness of breath, nausea, vomiting and diarrhea. The average length of stay for patients with comorbidities was 21 days and without comorbidities 14 days. The test results showed that there were clinical differences between patients with comorbid and non-cormobid patients with p value = 0.0000 (p>0.05) and there was a difference in length of stay with p-value = 0.001 (p>0.05). Conclusion : The clinical difference between covid-19 patients comorbid and non cormobid lies in the symptoms of headache with a longer duration of treatment, which is 22 days. More intensive treatment and care is needed for covid-19 patients with comorbid hypertension.

Item Type:	Article
Uncontrolled Keywords:	Clinical manifestation, COVID-19, Comorbid, Length of treatment
Subjects:	R Medicine > RA Public aspects of medicine > RA648.5-767 Epidemics. Epidemiology. Quarantine. Disinfection
Divisions:	Faculty of Nursing and Midwifery > Program Study of Nursing Bachelor
Depositing User:	Mr. . Bagas
Date Deposited:	02 Mar 2024 12:02
Last Modified:	14 Mar 2024 08:21
URI:	http://repository.unusa.ac.id/id/eprint/10683

Actions (login required)

View Item